Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson’s disease: a systematic review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson’s disease: a systematic review ; day:4 ; month:12 ; year:2024 ; pages:1-24
Clinical autonomic research ; (4.12.2024), 1-24
- Classification
-
Medizin, Gesundheit
- Creator
-
Galli, Silvia
De Carolis, Lanfranco
Bianchini, Edoardo
Alborghetti, Marika
Caliò, Bianca
Pacilio, Pierre
Fanciulli, Alessandra
Pontieri, Francesco E.
Rinaldi, Domiziana
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10286-024-01090-9
- URN
-
urn:nbn:de:101:1-2502182121304.880275441456
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Galli, Silvia
- De Carolis, Lanfranco
- Bianchini, Edoardo
- Alborghetti, Marika
- Caliò, Bianca
- Pacilio, Pierre
- Fanciulli, Alessandra
- Pontieri, Francesco E.
- Rinaldi, Domiziana
- SpringerLink (Online service)
Other Objects (12)
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease
PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease
PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease
PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease